Immunosuppressive properties of amino acid and peptide derivatives of mycophenolic acid. 2020

Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
Department of Organic Chemistry, Gdansk University of Technology, G. Narutowicza 11/12, 80-233, Gdansk, Poland.

Mycophenolic acid (MPA) was coupled with amino acids and biologically active peptides including derivatives of tuftsin to modify its immunosuppressive properties. Both amino acid unit in the case of simple MPA amides and modifications within peptide moiety of MPA - tuftsin conjugates influenced the observed activity. Antiproliferative potential of the obtained conjugates was investigated in vitro and MPA amides with threonine methyl ester and conjugate of MPA with retro-tuftisin occurred to be more selective against PBMC in comparison to parent MPA. Both amino acid and peptide derivatives of MPA acted as inosine-5'-monophosphate dehydrogenaze (IMPDH) inhibitors.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007168 IMP Dehydrogenase An enzyme that catalyzes the dehydrogenation of inosine 5'-phosphate to xanthosine 5'-phosphate in the presence of NAD. EC 1.1.1.205. Inosinic Acid Dehydrogenase,Inosine-5-Monophosphate Dehydrogenase,Acid Dehydrogenase, Inosinic,Dehydrogenase, IMP,Dehydrogenase, Inosine-5-Monophosphate,Dehydrogenase, Inosinic Acid,Inosine 5 Monophosphate Dehydrogenase
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
August 1976, Cancer research,
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
January 2017, Medicinal chemistry (Shariqah (United Arab Emirates)),
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
November 2013, European journal of medicinal chemistry,
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
December 2022, Journal of enzyme inhibition and medicinal chemistry,
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
August 1969, The Journal of antibiotics,
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
May 1964, Doklady Akademii nauk SSSR,
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
April 1971, Journal of medicinal chemistry,
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
July 2018, Marine drugs,
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
March 2017, International immunopharmacology,
Agnieszka Siebert, and Grzegorz Cholewiński, and Piotr Trzonkowski, and Janusz Rachon
April 1971, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
Copied contents to your clipboard!